• Convenient Viruses for Democrats series, Swine Flu

    From Leroy N. Soetoro@21:1/5 to All on Sun Sep 12 19:49:06 2021
    XPost: alt.health.virus.cure.alternatives, talk.politics.misc, sac.politics XPost: alt.fan.rush-limbaugh, talk.politics.guns

    https://www.cdc.gov/flu/swineflu/index.htm

    Swine influenza is a respiratory disease of pigs caused by type A
    influenza viruses that regularly cause outbreaks of influenza in pigs. Influenza viruses that commonly circulate in swine are called “swine
    influenza viruses” or “swine flu viruses.” Like human influenza viruses,
    there are different subtypes and strains of swine influenza viruses. The
    main swine influenza viruses circulating in U.S. pigs in recent years have been, swine triple reassortant (tr) H1N1 influenza virus, trH3N2 virus,
    and trH1N2 virus.

    https://www.cdc.gov/vaccinesafety/concerns/history/narcolepsy-flu.html

    Narcolepsy Following 2009 Pandemrix Influenza Vaccination in Europe
    An increased risk of narcolepsy was found following vaccination with
    Pandemrix, a monovalent 2009 H1N1 influenza vaccine that was used in
    several European countries during the H1N1 influenza pandemic. This risk
    was initially found in Finland, and then other European countries also
    detected an association.

    Background
    Narcolepsy is a central nervous system disorder characterized by excessive daytime sleepiness (EDS) and abnormal manifestations of rapid eye movement (REM) sleep. This disorder is caused by the brain’s inability to regulate sleep-wake cycles normally, but it can be treated with medication and
    behavior modification. About narcolepsy and other sleep disorders.

    Pandemrix is manufactured by GlaxoSmithKline in Europe and was
    specifically produced for pandemic 2009 H1N1 influenza. It was not used
    before 2009, and has not been used since the influenza pandemic season (2009-2010). It contains an oil-in-water emulsion adjuvant called ASO3. Adjuvants are substances added to a vaccine to increase the body’s immune response to that vaccine. More about adjuvants.



    Similarities between H1N1 and COVID-19

    Transmission
    Both 2009 H1N1 influenza and COVID-19 can be transmitted in similar ways.
    These include:

    Respiratory droplets. These are tiny droplets that are made when a person
    who has the virus talks, sneezes, or coughs. If you inhale these droplets,
    you can contract the virus.
    Contaminated objects. Respiratory droplets containing virus can land on
    things like countertops and doorknobs. You can contract the virus by
    touching these things and then touching your mouth, nose, or eyes.
    It’s also possible for a person to pass both viruses when they don’t have
    any symptoms. This is called asymptomatic transmission.

    Symptoms
    Both 2009 H1N1 influenza and COVID-19 are respiratory infections that
    share many symptoms in common. These can include:

    fever and chills
    fatigue
    cough
    body aches and pains
    headache
    sore throat
    runny or stuffy nose
    digestive symptoms like diarrhea and vomiting
    One symptom that’s unique to COVID-19 is loss of smell and taste.

    The 2009 H1N1 influenza and COVID-19 can range from mild to severe. In
    both pandemics, certain groups were at an increased risk for severe
    illness.

    Risk factors
    The groups at risk for complications from 2009 H1N1 influenza and COVID-19
    have significant overlap. They include:

    adults aged 65 and over
    pregnant people
    those with certain types of underlying health conditions
    Underlying health conditions that can contribute to complications include:

    chronic lung diseases, such as asthma, chronic obstructive pulmonary
    disorder (COPD), and cystic fibrosis
    developmental disorders like Down syndrome
    diabetes
    heart disease, including heart failure or coronary artery disease
    kidney disease
    liver disease
    neurological conditions, such as stroke and dementia
    sickle cell disease
    weakened immune system due to cancer treatments, HIV/AIDS, or
    immunosuppressive drugs
    Additional high risk groups for the 2009 H1N1 influenza
    Some additional groups that were at a higher riskTrusted Source for
    serious illness during the 2009 H1N1 influenza pandemic included:

    children under the age of 5
    people under the age of 19 who were receiving long-term aspirin therapy Additional high risk groups for COVID-19
    Additionally, people with the following underlying health conditions are
    at a higher riskTrusted Source for severe illness from COVID-19:

    hypertension
    having overweight or obesity
    smoking
    substance use disorders
    Complications
    Both 2009 H1N1 influenza and COVID-19 can lead to similar complications, including:

    pneumonia
    worsening of underlying health conditions
    secondary bacterial infections
    respiratory failure
    inflammation of tissues of the heart, brain, or muscles
    injury to the kidneys or liver
    acute respiratory distress syndrome (ARDS)
    sepsis
    COVID-19 also has a few additional complications, including:

    long-haul COVID
    blood clots
    multisystem inflammatory syndrome in children (MIS-C)

    --

    "LOCKDOWN", left-wing COVID fearmongering. 95% of COVID infections
    recover with no after effects.
    No collusion - Special Counsel Robert Swan Mueller III, March 2019.
    Officially made Nancy Pelosi a two-time impeachment loser.

    Donald J. Trump, cheated out of a second term by fraudulent "mail-in"
    ballots. Report voter fraud: sf.nancy@mail.house.gov

    Thank you for cleaning up the disaster of the 2008-2017 Obama / Biden
    fiasco, President Trump.

    Under Barack Obama's leadership, the United States of America became the
    The World According To Garp. Obama sold out heterosexuals for Hollywood
    queer liberal democrat donors.

    President Trump boosted the economy, reduced illegal invasions, appointed dozens of judges and three SCOTUS justices.

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)